Cargando…
Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report
BACKGROUND: Immunocompromised (IC) patients have an increased risk of refractory diarrhea. Fecal microbiota transplantation (FMT) is a safe and effective therapy for infection-related diarrhea which are mainly mediated by the loss of the microbial colonization, although there is concern that IC pati...
Autores principales: | Zhong, Shuwen, Zeng, Jingqing, Deng, Zhaohui, Jiang, Lirong, Zhang, Bin, Yang, Kaihua, Wang, Wenyu, Zhang, Tianao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714385/ https://www.ncbi.nlm.nih.gov/pubmed/31462301 http://dx.doi.org/10.1186/s13052-019-0708-9 |
Ejemplares similares
-
Fecal Microbiota Transplantation (FMT) for Recurrent/Refractory Clostridium difficile Infection (CDI) in Pediatric Immunocompromised Patients: A Single-center Experience
por: Kwendakwema, Natasha, et al.
Publicado: (2017) -
Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017) -
Rescue fecal microbiota transplantation for antibiotic-associated diarrhea in critically ill patients
por: Dai, Min, et al.
Publicado: (2019) -
Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients
por: Wardill, H.R., et al.
Publicado: (2019) -
606 Noroviruses (NoVs) as a Cause of Diarrhea in Immunocompromised Pediatric Transplant Recipients
por: Koo, Hoonmo L., et al.
Publicado: (2014)